PROTEON THERAPEUTICS INC - COM (PRTO)

CUSIP: 74371L109

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COM
Total 13F shares
9,127,786
Share change
+113,934
Total reported value
$126,321,268
Price per share
$13.91
Number of holders
40
Value change
+$1,121,370
Number of buys
15
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 74371L109?
CUSIP 74371L109 identifies PRTO - PROTEON THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTEON THERAPEUTICS INC - COM (PRTO) as of Q3 2015

As of 30 Sep 2015, PROTEON THERAPEUTICS INC - COM (PRTO) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,127,786 shares. The largest 10 holders included Abingworth LLP, RA CAPITAL MANAGEMENT, LLC, DEERFIELD MANAGEMENT CO, MPM ASSET MANAGEMENT LLC, FMR LLC, TIVERTON ASSET MANAGEMENT LLC, Deer VII & Co. Ltd., PERCEPTIVE ADVISORS LLC, BAKER BROS. ADVISORS LP, and Omega Fund Management, LLC. This page lists 40 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.